Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000303646, also known as “novel transcript, antisense to CLEC18C,” is annotated as a non-coding RNA gene on the opposite strand of the CLEC18C gene region. It does not encode a protein and is classified as an antisense RNA, potentially regulating CLEC18C transcript levels through RNA-RNA interaction or RNA interference pathways, though such regulatory roles are hypothetical and currently uncharacterized in available research and databases[1]. No established biological function, disease relevance, or role as a therapeutic target has been reported for this transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CLEC18C (ENSG00000303646).